We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.24B
AUM Growth
+$126M
(+6%)
Cap. Flow
+$70.8M
Cap. Flow
% of AUM
3.17%
Top 10 Holdings %
Top 10 Hldgs %
8.01%
Holding
1,947
New
521
Increased
417
Reduced
381
Closed
620
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$23.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$19.1M |
| 3 |
Alkermes
ALKS
|
+$17.1M |
| 4 |
Pfizer
PFE
|
+$16.5M |
| 5 |
DATA
Tableau Software, Inc.
DATA
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$16.1M |
| 2 |
Amazon
AMZN
|
+$14.2M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$14.1M |
| 4 |
CELG
Celgene Corp
CELG
|
+$13.7M |
| 5 |
Cognizant
CTSH
|
+$13.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.27% |
| 2 | Consumer Discretionary | 13.22% |
| 3 | Healthcare | 12.7% |
| 4 | Industrials | 10.58% |
| 5 | Energy | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Nucor
NUE
$56.4B
| $4.92M | 0.22% |
103,988
-12,900
| -11% | -$525K |
|
102
Vertex Pharmaceuticals
VRTX
$121B
| $4.91M | 0.22% |
61,769
+11,800
| +24% | +$1.07M |
|
|
MRO
103
DELISTED
Marathon Oil Corporation
MRO
| $4.88M | 0.22% |
437,757
+277,100
| +172% | +$2.59M |
|
104
Centene
CNC
$31.3B
| $4.8M | 0.21% |
155,956
+147,908
| +1,838% | +$4.42M |
|
|
BRCD
105
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $4.79M | 0.21% |
452,913
+337,700
| +293% | +$3.08M |
|
|
MDVN
106
DELISTED
MEDIVATION, INC.
MDVN
| $4.79M | 0.21% |
+104,160
| New | +$3.78M |
|
107
Salesforce
CRM
$134B
| $4.77M | 0.21% |
64,663
-27,225
| -30% | -$1.87M |
|
108
Edwards Lifesciences
EW
$47.6B
| $4.77M | 0.21% |
162,210
-18,900
| -10% | -$521K |
|
109
FirstEnergy
FE
$28.9B
| $4.75M | 0.21% |
132,146
-22,800
| -15% | -$766K |
|
110
Dollar General
DG
$25.9B
| $4.74M | 0.21% |
+55,393
| New | +$4.19M |
|
|
RHT
111
DELISTED
Red Hat Inc
RHT
| $4.7M | 0.21% |
63,056
-30,900
| -33% | -$2.18M |
|
112
Home Depot
HD
$332B
| $4.68M | 0.21% |
35,107
+13,500
| +62% | +$1.68M |
|
113
HCA Healthcare
HCA
$84.8B
| $4.55M | 0.2% |
58,278
+53,900
| +1,231% | +$3.76M |
|
114
Upbound Group
UPBD
$1.19B
| $4.54M | 0.2% |
286,762
+240,500
| +520% | +$3.21M |
|
115
Baxter International
BAX
$11.6B
| $4.54M | 0.2% |
+110,479
| New | +$4.21M |
|
|
TLRD
116
DELISTED
Tailored Brands, Inc.
TLRD
| $4.51M | 0.2% |
+252,252
| New | +$3.89M |
|
|
SPN
117
DELISTED
Superior Energy Services, Inc.
SPN
| $4.44M | 0.2% |
33,167
+24,390
| +278% | +$2.66M |
|
|
LM
118
DELISTED
Legg Mason, Inc.
LM
| $4.44M | 0.2% |
127,975
-8,800
| -6% | -$276K |
|
119
AbbVie
ABBV
$458B
| $4.43M | 0.2% |
77,522
-197,400
| -72% | -$11M |
|
|
CMRX
120
DELISTED
Chimerix, Inc.
CMRX
| $4.42M | 0.2% |
866,059
+838,200
| +3,009% | +$5.47M |
|
|
K
121
DELISTED
Kellanova
K
| $4.4M | 0.2% |
+61,200
| New | +$4.23M |
|
122
Camden Property Trust
CPT
$11.3B
| $4.39M | 0.2% |
52,182
+30,200
| +137% | +$2.31M |
|
123
Marvell Technology
MRVL
$174B
| $4.36M | 0.19% |
422,425
+372,800
| +751% | +$3.44M |
|
|
HTWR
124
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $4.35M | 0.19% |
138,512
+99,500
| +255% | +$3.37M |
|
125
Acadia Pharmaceuticals
ACAD
$4.25B
| $4.35M | 0.19% |
155,645
+148,208
| +1,993% | +$3.23M |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, A.R.T. Advisors held 1,947 positions worth $2.24B, up 6% from $2.11B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
A.R.T. Advisors deployed $70.8M of net new capital in Q1 2016, opening 521 new positions and adding to 417 existing holdings. Its largest new stake was Johnson & Johnson: 184,533 shares worth $20M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Cognizant, an estimated $13.6M trimmed.
- A.R.T. Advisors's largest Q1 2016 buy was Johnson & Johnson: 184,533 shares worth $20M.
- A.R.T. Advisors added most to LinkedIn Corporation in Q1 2016, an estimated $23.3M increase.
- A.R.T. Advisors's biggest Q1 2016 reduction was Cognizant, cutting an estimated $13.6M.
- A.R.T. Advisors fully exited Mastercard in Q1 2016, selling an estimated $16.1M.
- A.R.T. Advisors's ten largest holdings make up 8% of its $2.24B portfolio in Q1 2016.
- A.R.T. Advisors opened 521 new positions and closed 620 in Q1 2016.
- A.R.T. Advisors's portfolio value rose 6% quarter-over-quarter to $2.24B.
Based on A.R.T. Advisors's 13F filing for Q1 2016, filed 16 May 2016.